Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine
- 28 January 2014
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 32 (13), 1473-1479
- https://doi.org/10.1016/j.vaccine.2014.01.028
Abstract
No abstract availableFunding Information
- Henry M. Jackson Foundation for the Advancement of Military Medicine (W81XWH-07-2-067)
- U.S. Army Medical Research and Materiel Command (MRMC)
- National Institute on Drug Abuse (1DP1DA034787-01)
- NIH Intramural Research Programs of the National Institute on Drug Abuse
- National Institute of Alcohol Abuse and Alcoholism
- NIH
- DHHS
This publication has 15 references indexed in Scilit:
- Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogsVaccine, 2013
- Dynamic vaccine blocks relapse to compulsive intake of heroinProceedings of the National Academy of Sciences of the United States of America, 2013
- Selective Effects of a Morphine Conjugate Vaccine on Heroin and Metabolite Distribution and Heroin-Induced Behaviors in RatsThe Journal of pharmacology and experimental therapeutics, 2012
- Investigating the Effects of a Hydrolytically Stable Hapten and a Th1 Adjuvant on Heroin Vaccine PerformanceJournal of Medicinal Chemistry, 2012
- Vaccines Against Drug AbuseClinical Pharmacology & Therapeutics, 2011
- A Vaccine Strategy that Induces Protective Immunity against HeroinJournal of Medicinal Chemistry, 2011
- Applications and recent developments of multi-analyte simultaneous analysis by enzyme-linked immunosorbent assaysJournal of Immunological Methods, 2011
- Anti‐drug vaccines to treat substance abuseImmunology & Cell Biology, 2009
- A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodentsVaccine, 2006
- The concepts of crossreactivity and specificity in immunologyMolecular Immunology, 1981